Skip to main content
Signal8
Santos Carlos E profile photo

Carlos E. Santos

CIK: 0002097065

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Legend Biotech Corp logo
LEGN

Legend Biotech Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Legend Biotech Corp logo
    LEGN

    Legend Biotech Corp

    Sep 21, 2026
    Award(A)
    Direct
    19.7K shares-
  • Legend Biotech Corp logo
    LEGN

    Legend Biotech Corp

    Sep 21, 2026
    Sale(S)
    Direct
    5.4K shares at avg. $9.14$50K

1-2 of 2

About Santos Carlos E

Santos Carlos E (SEC CIK 0002097065) files insider reports with the SEC as Chief Financial Officer of Legend Biotech Corp (LEGN).

Signal8 holds 2 ownership filings by Santos Carlos E (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Sep 23, 2026. Those filings report 2 transactions, the latest on Sep 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Santos Carlos E's filings is in BRIDGEWATER, NJ.

Recent filings by Santos Carlos E

  • Sep 21, 2026: Grant or award of LEGN shares (Form 4, code A).
  • Sep 21, 2026: Open-market sale of LEGN shares (Form 4, code S).

Other insiders filing for Legend Biotech Corp (LEGN)

How to read Form 4 transaction codes